PRESS RELEASE
News
-
-
-
PRESS RELEASE
Original-Research: Scandinavian Astor Group AB (von NuWays AG): BUY
Scandinavian Astor Group AB's Q3 results show strong sales growth of 79% yoy, reaching SEK 79m, and a significant EBITDA margin increase to 19% in a 'weak' quarter. Analyst maintains BUY rating with SEK 56.00 target price -
-
-
PRESS RELEASE
11880 Solutions AG expands its review portal werkenntdenBESTEN: New design, review highlights and cooperation with GetYourGuide ensure better orientation
11880 Solutions AG expands review portal werkenntdenBESTEN with new design, review highlights & partnership with GetYourGuide for better user experience & convenience -
-
PRESS RELEASE
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
New phase 2 data presented at ESMO Congress highlight AlphaMedix as a promising targeted alpha therapy for GEP-NETs, showing high response rates and potential to address unmet medical needs -
PRESS RELEASE
Communiqué de presse : ESMO : les données de l’essai de phase 2 soulignent le potentiel thérapeutique prometteur d’AlphaMedix™ en tant que pionnier de la nouvelle classe des alphathérapies ciblées contre les tumeurs neuroendocrines (...)
Les nouvelles données de l'essai de phase 2 ALPHAMEDIX-02 soulignent le potentiel thérapeutique prometteur d'AlphaMedix™ pour les tumeurs neuroendocrines gastro-entéro-pancréatiques (TNE-GEP), avec des réponses prolongées et significatives chez les patients -
